Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials.
Bellerba F, Chatziioannou AC, Jasbi P, Robinot N, Keski-Rahkonen P, Trolat A, Vozar B, Hartman SJ, Scalbert A, Bonanni B, Johansson H, Sears DD, Gandini S. Bellerba F, et al. Among authors: johansson h. J Transl Med. 2022 Dec 29;20(1):629. doi: 10.1186/s12967-022-03809-6. J Transl Med. 2022. PMID: 36581893 Free PMC article.
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Decensi A, et al. Among authors: johansson h. Clin Cancer Res. 2004 Jul 1;10(13):4389-97. doi: 10.1158/1078-0432.CCR-04-0087. Clin Cancer Res. 2004. PMID: 15240527 Clinical Trial.
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
Guerrieri-Gonzaga A, Robertson C, Bonanni B, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Formelli F, Intra M, Latronico A, Franchi D, Pelosi G, Johnson K, Decensi A. Guerrieri-Gonzaga A, et al. Among authors: johansson h. J Clin Oncol. 2006 Jan 1;24(1):129-35. doi: 10.1200/JCO.2005.02.9934. J Clin Oncol. 2006. PMID: 16382122 Clinical Trial.
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A. Macis D, et al. Among authors: johansson h. Breast Cancer Res Treat. 2007 Dec;106(2):263-71. doi: 10.1007/s10549-006-9491-6. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260091
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.
Decensi A, Gandini S, Serrano D, Cazzaniga M, Pizzamiglio M, Maffini F, Pelosi G, Daldoss C, Omodei U, Johansson H, Macis D, Lazzeroni M, Penotti M, Sironi L, Moroni S, Bianco V, Rondanina G, Gjerde J, Guerrieri-Gonzaga A, Bonanni B. Decensi A, et al. Among authors: johansson h. J Clin Oncol. 2007 Sep 20;25(27):4201-9. doi: 10.1200/JCO.2006.09.4318. Epub 2007 Aug 20. J Clin Oncol. 2007. PMID: 17709798 Clinical Trial.
1,435 results